Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuji Kashitani

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 2023
[Current Status and Issues in Drug Development for Rare Cancers]Yuji Kashitani, Hironori Takayama, Natsuko Hamada, et al.
Therapeutic Innovation & Regulatory Science|August 21, 2025
Implementation of Established Conditions and Use of Quality by Design Principles during Drug Development: Status in the US, EU, and Japan. Data from a Survey Conducted by the Japan Pharmaceutical Manufacturers Association (JPMA)Yoshio Nakayama, Sonoko Yamauchi, Kozue Shimizume, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 2023
[Current Status and Issues in Drug Development for Rare Cancers]Yuji Kashitani, Hironori Takayama, Natsuko Hamada, et al.
Therapeutic Innovation & Regulatory Science|August 21, 2025
Implementation of Established Conditions and Use of Quality by Design Principles during Drug Development: Status in the US, EU, and Japan. Data from a Survey Conducted by the Japan Pharmaceutical Manufacturers Association (JPMA)Yoshio Nakayama, Sonoko Yamauchi, Kozue Shimizume, et al.
Pageof 1